BlackRock Health Sciences Trust II
BMEZ
89 hedge funds and large institutions have $257M invested in BlackRock Health Sciences Trust II in 2026 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 24 reducing their positions, and 12 closing their positions.
38% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 24
19% more capital invested
Capital invested by funds: $215M → $257M (+$41.6M)
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
12.58% more ownership
Funds ownership: 14.08% → 26.66% (+13%)
1% more funds holding
Funds holding: 88 → 89 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
+$10.2M |
| 2 |
SCM
Saba Capital Management
New York
|
+$8.47M |
| 3 |
AW
Atlas Wealth
Cincinnati,
Ohio
|
+$7.19M |
| 4 |
SIA
Sit Investment Associates
Minneapolis,
Minnesota
|
+$3.9M |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$2.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$5.45M |
| 2 |
Morgan Stanley
New York
|
-$2.08M |
| 3 |
QC
Quantedge Capital
Singapore
|
-$1.37M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.21M |
| 5 |
1CP
1607 Capital Partners
Richmond,
Virginia
|
-$1.04M |
BMEZ Hedge Fund Activity: Q2 2026 in Review
89 of the 8,316 institutional investors tracked by Wall St. Rank reported a position in BlackRock Health Sciences Trust II (BMEZ) for Q2 2026, worth a combined $257M — up 19% from $215M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new BMEZ positions and 12 closed out — a net gain of 2 holders — while 33 added to existing stakes and 24 trimmed.
The largest buyer was Lazard Asset Management, adding an estimated $10.2M. The largest seller was Wolverine Asset Management, exiting entirely with an estimated $5.45M sold.
- 89 institutional investors held BlackRock Health Sciences Trust II (BMEZ) as of Q2 2026, up from 88 in Q1 2026.
- Funds reported $257M of BlackRock Health Sciences Trust II stock for Q2 2026, up 19% quarter-over-quarter.
- 14 funds opened new BlackRock Health Sciences Trust II positions in Q2 2026 and 12 closed out, a net change of +2 holders.
- The largest BlackRock Health Sciences Trust II buyer in Q2 2026 was Lazard Asset Management, an estimated $10.2M added.
- The largest BlackRock Health Sciences Trust II seller in Q2 2026 was Wolverine Asset Management, an estimated $5.45M sold.
Based on aggregated 13F filings for Q2 2026.